Expression levels of Lyn, Syk, PLCγ2 and ERK in patients with chronic lymphocytic leukemia, and higher levels of Lyn are associated with a shorter treatment-free survival

Leukemia and Lymphoma

Volumn 54, Issue 6, 2013, Pages 1165-1170

  Wang, Yin Hua ^a   Fan, Lei ^a   Wang, Li ^a   Zhang, Run ^a   Zou, Zhi Jian ^a   Fang, Cheng ^a   Zhang, Li Na ^a   Li, Jian Yong ^a   Xu, Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

B cell receptor signaling; Chronic leukemia lymphoma; ERK; Lyn; PLC 2; Syk; ZAP 70

Indexed keywords

B LYMPHOCYTE RECEPTOR; BETA 2 MICROGLOBULIN; CD38 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; LACTATE DEHYDROGENASE; MESSENGER RNA; METHYLPREDNISOLONE; RITUXIMAB; THYMIDINE KINASE 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; DRUG MEGADOSE; ERK GENE; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LYN GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; PLCGAMMA2 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SYK GENE; TREATMENT RESPONSE; ZAP 70 GENE;

ADULT; AGED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PHOSPHOLIPASE C GAMMA; PROGNOSIS; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; ROC CURVE; SRC-FAMILY KINASES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84877760542     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.736983     Document Type: Article

References (28)

1. Caligaris-Cappio F, Hamblin TJ . B-cell chronic lymphocytic leukemia: A bird of a diff erent feather . J Clin Oncol 1999; 17 : 399 - 408.
2. G entile M, M auro F R, G uarini A, et a l. N ew developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemia. Curr Opin Oncol 2005; 17 : 597 - 604.
3. Hamblin TJ, Davis Z, Gardiner A, et al . Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia . Blood 1999; 94 : 1848 - 1854.
4. R osenwald A, A lizadeh A A, W idhopf G, et a l. R elation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia . J Exp Med 2001; 194: 1639- 1647.
5. Crespo M, Bosch F, Villamor N, et al . ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia . N Engl J Med 2003; 348: 1764- 1775.
6. O rchard J A, I bbotson R E, D avis Z, et a l. Z AP-70 expression and prognosis in chronic lymphocytic leukaemia . Lancet 2004; 363 : 105 - 111.
7. R assenti L Z, H uynh L, T oy T L, et a l. Z AP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia . N Engl J Med 2004; 351 : 893 - 901.
8. Rodriguez A, Villuendas R, Yanez L, et al . Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: Clinical correlation. Leukemia 2007; 21: 1984- 1991.
9. Dal Porto JM, Gauld SB, Merrell KT, et al . B cell antigen receptor signaling 101. Mol Immunol 2004; 41: 599- 613.
10. Kong GH, Bu JY, Kurosaki T, et al . Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase . Immunity 1995; 2 : 485 - 492.
11. C heson B D, B ennett J M, G rever M, et a l. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment . Blood 1996; 87 : 4990 - 4997.
12. B inet J L, A uquier A, D ighiero G, et a l. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis . Cancer 1981; 48: 198- 206.
13. Xu W, Li JY, Wu YJ, et al . CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia . Leuk Res 2009; 33 : 237 - 243.
14. Chen L, Zhang Y, Zheng W, et al . Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia . Leuk Res 2008; 32: 1491- 1498.
15. Qiu HX, Xu W, Cao XS, et al . Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: A prospective, multicenter study on 143 cases analysed with interphase fl uorescence in situ hybridisation. Leuk Lymphoma 2008; 49: 1887- 1892.
16. Xu W, Cao X, Miao KR, et al . Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors . Int J Hematol 2009; 90 : 205 - 211.
17. Wang YH, Zou ZJ, Liu L, et al . Quantifi cation of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia . J Cancer Res Clin Oncol 2012; 138 : 1011 - 1017.
18. K eshvara L M, I saacson C C, Y ankee T M, et a l. S yk- and Lyndependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling. J Immunol 1998; 161 : 5276 - 5283.
19. Campbell KS . Signal transduction from the B cell antigen-receptor. Curr Opin Immunol 1999; 11 : 256 - 264.
20. C hen L, W idhopf G, H uynh L, et a l. E xpression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia . Blood 2002; 100: 4609- 4614.
21. Chen L, Apgar J, Huynh L, et al . ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia . Blood 2005; 105 : 2036 - 2041.
22. Gobessi S, Laurenti L, Longo PG, et al . ZAP-70 enhances Bcell- receptor signaling despite absent or ineffi cient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. Blood 2007; 109 : 2032 - 2039.
23. Chen L, Huynh L, A pgar J, et a l. Z AP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia. Blood 2008; 111 : 2685 - 2692.
24. Magnac C, Porcher R, Davi F, et al . Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL . Leukemia 2003; 17 : 133 - 137.
25. Kheirallah S, Caron P, Gross E, et al . Rituximab inhibits B-cell receptor signaling . Blood 2010; 115: 985- 994.
26. C ontri A, B runati A M, T rentin L, et a l. C hronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis . J Clin Invest 2005; 115: 369- 378.
27. Young RM, Hardy IR, Clarke RL, et al . Mouse models of non- Hodgkin lymphoma reveal Syk as an important therapeutic target. Blood 2009; 113 : 2508 - 2516.
28. Hussein K, von Neuhoff N, B üsche G, et al . Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies . Ann Hematol 2009; 88: 1059- 1067.